Your browser doesn't support javascript.
loading
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation.
Canu, Valeria; Donzelli, Sara; Sacconi, Andrea; Lo Sardo, Federica; Pulito, Claudio; Bossel, Noa; Di Benedetto, Anna; Muti, Paola; Botti, Claudio; Domany, Eytan; Bicciato, Silvio; Strano, Sabrina; Yarden, Yosef; Blandino, Giovanni.
Afiliación
  • Canu V; Oncogenomic and Epigenetic Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Donzelli S; Oncogenomic and Epigenetic Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Sacconi A; Clinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Lo Sardo F; Oncogenomic and Epigenetic Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Pulito C; Oncogenomic and Epigenetic Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Bossel N; Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, 7610001, Israel.
  • Di Benedetto A; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Muti P; Department of Biomedical Science and Oral Health, University of Milan, Milan, 20122, Italy.
  • Botti C; Breast Surgery Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Domany E; Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, 7610001, Israel.
  • Bicciato S; Center for Genome Research, Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Strano S; SAFU Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Yarden Y; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, 7610001, Israel.
  • Blandino G; Oncogenomic and Epigenetic Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy. giovanni.blandino@ifo.gov.it.
Cell Death Differ ; 28(5): 1493-1511, 2021 05.
Article en En | MEDLINE | ID: mdl-33230261

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias de la Mama / Biomarcadores de Tumor / Proteínas de Ciclo Celular Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Cell Death Differ Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias de la Mama / Biomarcadores de Tumor / Proteínas de Ciclo Celular Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Cell Death Differ Año: 2021 Tipo del documento: Article País de afiliación: Italia